$165.00
KLOW 80MG is a multi-peptide research formulation combining BPC-157, TB-500 (Thymosin Beta-4 fragment), KPV (Lys-Pro-Val), and GHK-Cu (Copper Tripeptide-1), studied for their roles in cellular signaling, inflammatory pathway modulation, cytoskeletal dynamics, and peptide–metal regulatory mechanisms. Each component is investigated for distinct receptor-associated and intracellular signaling properties. Preclinical research utilizes this combination to explore peptide synergy, extracellular matrix interaction, redox-associated pathways, and coordinated cellular communication under controlled laboratory conditions.
For research use only. Not for human consumption.
References:
Goldstein AL et al., Ann N Y Acad Sci, 1993
Pickart L et al., BioMed Res Int, 2015
Catania A et al., Peptides, 2004
KLOW 80MG is a laboratory research formulation designed to examine coordinated peptide-mediated cellular signaling mechanisms. It combines four extensively studied peptides associated with extracellular matrix regulation, inflammatory signaling pathways, cytoskeletal interaction, and redox-associated cellular processes.
Biochemical Characteristics
BPC-157 is a synthetic pentadecapeptide investigated for growth-related signaling dynamics.
TB-500 is derived from thymosin beta-4 and studied for actin-binding and cytoskeletal regulatory pathways.
KPV is a tripeptide fragment associated with melanocortin-related signaling research.
GHK-Cu is a copper-binding tripeptide complex studied for metalloprotein modulation and redox-associated mechanisms.
Research Applications
This peptide combination is utilized in research models investigating inflammatory pathway modulation, extracellular matrix signaling, cytoskeletal dynamics, peptide–metal interactions, and coordinated cellular regulatory mechanisms under controlled laboratory conditions.
Pathway / Mechanistic Context
Mechanistic research focuses on growth factor–associated signaling cascades, actin polymerization pathways, melanocortin-related modulation mechanisms, metalloprotein activity, and redox-dependent intracellular signaling networks.
Preclinical Research Summary
Preclinical investigations have evaluated BPC-157, TB-500, KPV, and GHK-Cu individually and in combined experimental models to better understand peptide-driven signaling synergy and cellular pathway coordination.
Form & Analytical Testing
KLOW 80MG is supplied as a multi-peptide research formulation. Each component undergoes analytical verification, including HPLC testing, to confirm identity, purity (99%), and composition consistency suitable for laboratory research use.
RUO Disclaimer
This product is intended strictly for research and laboratory use only. It is not approved for human consumption, medical treatment, veterinary use, cosmetic application, or diagnostic purposes. Handling should be performed only by qualified professionals trained in proper laboratory procedures.
Reviews
There are no reviews yet.